These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2887139

  • 1. [Tardive dyskinesias of neuroleptics. Major complications of long-term neuroleptic treatment].
    Bourgeois M.
    Ann Med Psychol (Paris); 1987 Feb; 145(2):156-60. PubMed ID: 2887139
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J.
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [Abstract] [Full Text] [Related]

  • 3. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
    Lam RW, Jeste SD, Jeste DV.
    Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
    [Abstract] [Full Text] [Related]

  • 4. [Neuroleptic-induced tardive dyskinesias in France].
    Bourgeois M.
    Encephale; 1988 Sep; 14 Spec No():195-201. PubMed ID: 2905646
    [Abstract] [Full Text] [Related]

  • 5. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
    D'Aquila F, Rampello L.
    Riv Neurol; 1990 Sep; 60(4):140-5. PubMed ID: 1982720
    [Abstract] [Full Text] [Related]

  • 6. [Tardive dyskinesia].
    Sabbatini F, Gentile S, De Mattei M, Pinessi L, Rainero I.
    Minerva Med; 1985 Apr 14; 76(16):797-802. PubMed ID: 2860619
    [Abstract] [Full Text] [Related]

  • 7. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA, Yassa R, Llorca PM.
    Encephale; 1993 Apr 14; 19(6):657-61. PubMed ID: 12404786
    [Abstract] [Full Text] [Related]

  • 8. [Medicolegal aspects of tardive dyskinesia in the United States].
    Wolf MA, Grunberg F, Garneau Y.
    Encephale; 1988 Apr 14; 14(3):133-8. PubMed ID: 2900134
    [Abstract] [Full Text] [Related]

  • 9. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A, Lajeunesse C.
    Encephale; 1988 Sep 14; 14 Spec No():209-14. PubMed ID: 2905648
    [Abstract] [Full Text] [Related]

  • 10. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G, Cole JO, Schniebolk S, Salomon M.
    J Clin Psychiatry; 1987 Sep 14; 48(9):359-62. PubMed ID: 2887550
    [Abstract] [Full Text] [Related]

  • 11. A summary of current knowledge of tardive dyskinesia.
    Baldessarini RJ.
    Encephale; 1988 Sep 14; 14 Spec No():263-8. PubMed ID: 2905654
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic drugs and tardive dyskinesia.
    Bittker TE.
    Ariz Med; 1981 Sep 14; 38(9):708-9. PubMed ID: 6117266
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tardive dyskinesia and glucid metabolism.
    Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.
    Hum Psychopharmacol; 2007 Aug 14; 22(6):373-80. PubMed ID: 17579925
    [Abstract] [Full Text] [Related]

  • 17. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
    Hoffmann C, Faust V.
    Fortschr Med; 1983 Mar 24; 101(11):470-6. PubMed ID: 6133824
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)].
    Gaillard-Sizaret C, Gaillard P.
    Therapie; 1979 Mar 24; 34(5):555-74. PubMed ID: 44767
    [No Abstract] [Full Text] [Related]

  • 20. [Risk factors and prevention of tardive dyskinesias].
    Wolf MA, Wertenschlag N.
    Can J Psychiatry; 1989 Apr 24; 34(3):177-81. PubMed ID: 2566366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.